Mirati therapeutics, inc. (MRTX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenue
License and collaboration revenues

267

-

988

577

1,244

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

267

526

988

577

1,244

3,459

0

0

9,467

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses
Research and Development Expense

71,708

62,940

47,362

38,324

34,240

26,758

23,626

23,829

19,659

15,244

13,482

14,962

14,397

15,952

16,106

18,441

17,988

14,913

14,563

11,276

8,207

7,076

6,886

7,149

4,960

4,320

5,492

4,510

5,475

4,249

3,652

General and administrative

18,046

12,232

10,685

9,894

9,762

6,373

5,313

4,841

5,154

2,984

3,119

3,654

3,693

3,901

3,475

3,786

4,130

3,575

4,161

4,240

3,779

3,366

3,662

2,986

2,685

2,554

3,717

2,382

2,524

1,717

1,082

Restructuring costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

334

1,025

0

0

0

-

-

Total operating expenses

89,754

75,172

58,047

48,218

44,002

33,131

28,939

28,670

24,813

18,228

16,601

18,616

18,090

19,853

19,581

22,227

22,118

18,488

18,724

15,516

11,986

10,442

10,548

10,135

7,979

7,899

9,209

6,892

7,999

5,966

4,734

Loss from operations

-89,487

-74,646

-57,059

-47,641

-42,758

-29,672

-28,939

-28,670

-15,346

-18,228

-16,601

-18,616

-18,090

-19,853

-19,581

-22,227

-22,118

-18,488

-18,724

-15,516

-11,986

-10,442

-10,548

-10,135

-7,979

-7,899

-9,209

-6,892

-7,999

-5,966

-4,734

Other income, net

2,832

2,270

2,786

1,946

1,846

1,400

1,371

801

637

333

251

277

244

131

160

166

204

71

-17

70

46

28

24

73

-202

-282

462

-694

-570

34

70

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-27

-1,907

976

5,475

3,189

20,596

385

-4,371

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,370

-29,343

-7,971

-4,198

-5,932

-4,664

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-138

55

41

19

14

13

Net Income (Loss) Attributable to Parent

-86,655

-72,376

-54,273

-45,695

-40,912

-28,272

-27,568

-27,869

-14,709

-17,895

-16,350

-18,339

-17,846

-19,722

-19,421

-22,061

-21,914

-18,417

-18,741

-15,446

-11,940

-10,387

-8,617

-11,038

-13,656

-11,232

-29,398

-8,012

-4,217

-5,946

-4,677

Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax

-182

-2

103

151

158

35

99

154

-288

-34

13

-104

71

-51

-34

33

27

35

6

-9

5

-8

-12

24

10

-13

0

0

0

-

-

Comprehensive loss

-86,837

-72,378

-54,170

-45,544

-40,754

-28,237

-27,469

-27,715

-14,997

-17,929

-16,337

-18,443

-17,775

-19,773

-19,455

-22,028

-21,887

-18,382

-18,735

-15,455

-11,935

-10,395

-8,629

-11,014

-13,646

-11,245

-29,398

-8,012

-4,217

-

-

Basic and diluted net loss per share (USD per share)

-2.02

-1.88

-1.38

-1.26

-1.17

-0.89

-0.85

-0.94

-0.51

-0.66

-0.65

-0.74

-0.73

-0.99

-0.97

-1.11

-1.13

-

-1.11

-0.95

-0.77

-

-

-0.82

-1.01

-

-

-0.80

-

-0.93

-0.73

Loss per share, basic (in US$ per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.64

-

-

-

-2.95

-

-0.42

-

-

Diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.72

-

-

-

-2.95

-

-0.68

-

-

Weighted average number of shares used in computing net loss per share, basic and diluted (shares)

42,886

39,518

39,197

36,173

34,980

32,578

32,410

29,757

28,843

26,856

24,970

24,950

24,383

19,931

19,924

19,912

19,380

19,076

16,841

16,235

15,453

-

-

13,498

13,457

-

-

9,957

-

6,361

6,358

Weighted average number of shares used in computing net loss per share, basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,527

-

-

-

9,957

-

9,957

-

-

Weighted average number of shares used in computing net loss per share, diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,717

-

-

-

9,957

-

10,078

-

-